A VC's take on the $1.3 billion acquisition of CinCor Pharma by AstraZeneca

Retrieved on: 2023-01-10 23:15:49

Tags for this article:

Click the tags to see associated articles and topics

A VC's take on the $1.3 billion acquisition of CinCor Pharma by AstraZeneca. View article details on hiswai:

Excerpt

Maina Bhaman, a board member of CinCor Pharma reflects on the news from Monday that AstraZeneca is acquiring the Massachusetts startup to bring ...

Article found on: medcitynews.com